Mental Health, Fatty Liver, and Resistant Hypertension episode artwork

EPISODE · May 23, 2025 · 12 MIN

Mental Health, Fatty Liver, and Resistant Hypertension

from TT HealthWatch · host Christina Acosta

This week's topics include treating resistant hypertension, gabapentanoids and the risk of self harm, risk for depression after diagnosis of a medical condition, and fatty liver and pregnancy.Program notes:0:35 Depression after medical condition diagnosis1:36 Any of a number of medical conditions2:37 A much lower risk in comparison group3:37 Major depressive disorder could be number one cause of YLL4:01 Fatty liver and pregnancy outcomes5:01 Matched to those with obesity or T2D6:01 Screening general population not indicated7:00 Gabapentanoids and risk of self harm8:01 Rates of self harm variable 9:04 Use has increased fourfold10:00 Treatment of resistant hypertension11:01 Spironolactone or amiloride12:33 End

Episode metadata supplied by the publisher feed · Published May 23, 2025

Embed this episode

This week's topics include treating resistant hypertension, gabapentanoids and the risk of self harm, risk for depression after diagnosis of a medical condition, and fatty liver and pregnancy.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Mental Health, Fatty Liver, and Resistant Hypertension

0:00 12:33

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TT HealthWatch?

This episode is 12 minutes long.

When was this TT HealthWatch episode published?

This episode was published on May 23, 2025.

Can I download this TT HealthWatch episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!